Navigation Links
3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology
Date:6/29/2012

MENLO PARK, Calif., June 29, 2012 /PRNewswire/ -- 3-V Biosciences, Inc., announced today the appointment of Douglas Buckley, PhD, as Vice President of Biology.  Dr. Buckley brings more than 25 years of experience in the biopharmaceutical industry, and his discoveries and research leadership have resulted in several marketed products and many more in clinical development.

"With our lead antiviral program entering the clinic in the next year, we are committed to building a strong pipeline.  Doug's extensive experience in target identification and prosecution and his track record of successful early-stage drug development will be instrumental to our continued growth," said George Kemble, PhD, 3-V's Chief Scientific Officer.

"I look forward to building upon the early successes of 3-V and developing the next generation of antiviral compounds with this team," said Dr. Buckley.  "3-V has taken a novel approach to antiviral therapies that are less likely to allow viral resistance to develop.  In addition, this approach opens up the possibility of developing high-value therapeutics in other therapeutic areas, making 3-V a compelling story." 

Dr. Buckley joins 3-V from Exelixis, Inc., where he served most recently as Vice President of Biochemistry.  In that role, he led research and discovery teams responsible for delivering over thirty IND-ready compounds to Exelixis' internal pipeline and to external partnerships.  Also during his tenure at Exelixis, Dr. Buckley contributed to the New Drug Application filing for cabozantinib (XL 184).   Prior to Exelixis, Dr. Buckley was the Department Head of Protein Chemistry and Process Development at Scios, Inc., where he was responsible for process and assay development for two marketed biotherapeutic products (Fiblast® (trafermin) and NATRECOR® (nesiritide)).  Doug received his AB in Chemistry and Economics from Bowdoin College, his PhD in Endoc
'/>"/>

SOURCE 3-V Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Amarantus BioSciences to Present at the National Investment Banking Associations (NIBA)122nd Conference in New York City
2. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
3. UCLAs Yi Tang receives Presidential Green Chemistry Challenge Award from EPA
4. President, CEO Leppävuori, VTT: Finland should create a national bioeconomy strategy
5. Oligonucleotide Delivery: Biology, Engineering and Development Conference
6. GW announces creation of Computational Biology Institute to conduct integrated research
7. MARC travel award announced for the 2012 GSA Yeast Genetics and Molecular Biology Meeting
8. Infection biology: The elusive third factor
9. Tips from the Journals of the American Society for Microbiology
10. MARC travel awards announced for the Society for Developmental Biology 71st Annual Meeting
11. The American Society for Microbiology honors Anthony R. Richardson
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... July 31, 2015 The 10 th International ... by BGI from October 22-25, 2015, in Shenzhen ... conference is celebrating its 10 th anniversary this year. Since ... world,s most influential annual meetings in the ,omics, fields, and ... gatherings. ICG-10 focuses on recent breakthroughs and ...
(Date:7/23/2015)... 23, 2015 Research and Markets ( ... "Global Outlook of the Biometrics Industry 2015 ... The global biometrics market is likely to ... applications owing to the uptake of multiple technologies ... that enhances the growth of biometrics in existing ...
(Date:7/13/2015)... , July 13, 2015 Synaptics Inc. ... human interface solutions, today announced sampling of ClearPad ... display driver integration (TDDI) product targeting smartphones and ... to combine Synaptics , best-in-class touch controller ... driver technology developed in the company,s Japan Design ...
Breaking Biology News(10 mins):The 10th International Conference on Genomics (ICG-10) to Open in October 2Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
... 22Nearly 6,000 researchers from around the world will present ... of light waves at the 2008 Conference on Lasers ... May 4-9 at the San Jose McEnery Convention Center ... preeminent event for those in the lasers and electro-optics ...
... origins of life and culminating with the latest findings ... will report on research spanning three billion years of ... symposium takes place on Thursday, May 1, and Friday, ... is free and open to the public. The ...
... Sharks in captivity avoid metals that react with seawater ... help fishery biologists develop a strategy to reduce the ... is an increasing priority worldwide given diminished populations of ... species for baited lines, reducing fishing efficiency and increasing ...
Cached Biology News:Detecting dangerous chemicals with lasers, exploring the brain's circuitry with light and more 2Detecting dangerous chemicals with lasers, exploring the brain's circuitry with light and more 3Detecting dangerous chemicals with lasers, exploring the brain's circuitry with light and more 4Detecting dangerous chemicals with lasers, exploring the brain's circuitry with light and more 5Detecting dangerous chemicals with lasers, exploring the brain's circuitry with light and more 6Detecting dangerous chemicals with lasers, exploring the brain's circuitry with light and more 7Rockefeller University hosts 2-day evolution symposium, May 1-2, 2008 2Can certain metals repel sharks from fishing gear? 2Can certain metals repel sharks from fishing gear? 3
(Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative ... study of its canine osteoarthritis stem cell product, currently under development for FDA ... and will be marketed in the US by Aratana. This product, termed AT-016, ...
(Date:7/30/2015)... Ascendis Pharma A/S (Nasdaq: ASND ... TransCon technology to address significant unmet medical needs, ... Phase 2 study to evaluate the safety and ... treatment-naïve, pre-pubertal children with growth hormone deficiency, or ... the top-line results from our Phase 2 pediatric ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... advanced fluid applications and designed for continuous operation up to 1500 bar. The ... ensuring safety, efficiency, and preventing toxic contamination. , The Pony™ NS2006L homogenizer is ...
(Date:7/29/2015)... 29, 2015 US-Australian drug discovery company, Novogen ... it is committed to progressing its ground-breaking technology platforms ... and to ensure the Company delivers the best value ... Iain Ross , said the Company currently had an ... programs, discovery programs and academic partnerships and initiatives, and ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10
... BrainPort technology will be discussed at a Monday, Oct. ... president and chief executive officer at Wicab , ... an overview of the business plan and the planned ... BrainPort balance device in the United States and Europe ...
... from company offices and using broadband services to help them ... by a Milwaukee company for ITAC , the Telework ... ,"The ability for people to work from anywhere is attributed ... communication technologies," said Robert L. Smith of ITAC, in Silver ...
... announced that Dick Blick ... Warehouse and RedPrairie DLx Labor at its distribution center in ... Highland Park, Ill., offers more than 30,000 art supply products ... , Analytical Surveys, Inc., ...
Cached Biology Technology:More Americans working away from the office 2
Formulation: Phosphate-buffered saline, pH 7.2, containing 0.09% sodium azide....
... The Luminex 100 Instrument System is ... assays using Upstate's Beadlyte reagents. The ... Dell computer with software version 1.7, ... Delivery System. Upstate offers $2000 in ...
normal human fibroblasts Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Purified anti-Fanconi anemia D2-Phosphorylated (Ser222)...
Biology Products: